3CUK

Crystal structure of human D-amino acid oxidase: bound to an inhibitor

Summary for 3CUK

• Entry DOI: 10.2210/pdb3cuk/pdb
• Descriptor: D-amino-acid oxidase, FLAVIN-ADENINE DINUCLEOTIDE, 4H-furo[3,2-b]pyrrole-5-carboxylic acid, ... (4 entities in total)
• Functional Keywords: oxidoreductase, alpha-beta-alpha motif, flavin containing proteinalpha-beta-alpha motif, flavin containing protein, fad, flavoprotein, peroxisome
• Biological source: Homo sapiens
• Cellular location: Peroxisome: P14920
• Total number of polymer chains: 4
• Total formula weight: 161830.32

Authors

Prasad, S.,Munshi, S. (deposition date: 2008-04-16, release date: 2008-07-22, Last modification date: 2023-08-30)

Primary citation

Sparey, T.,Abeywickrema, P.,Almond, S.,Brandon, N.,Byrne, N.,Campbell, A.,Hutson, P.H.,Jacobson, M.,Jones, B.,Munshi, S.,Pascarella, D.,Pike, A.,Prasad, G.S.,Sachs, N.,Sakatis, M.,Sardana, V.,Venkatraman, S.,Young, M.B.
The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.
Bioorg.Med.Chem.Lett., 18:3386-3391, 2008

PubMed Abstract: The 'NMDA hypofunction hypothesis of schizophrenia' can be tested in a number of ways. DAO is the enzyme primarily responsible for the metabolism of d-serine, a co-agonist for the NMDA receptor. We identified novel DAO inhibitors, in particular, acid 1, which demonstrated moderate potency for DAO in vitro and ex vivo, and raised plasma d-serine levels after dosing ip to rats. In parallel, analogues were prepared to survey the SARs of 1.

PubMed: 18455394
DOI: 10.1016/j.bmcl.2008.04.020

Experimental method

X-RAY DIFFRACTION (2.49 Å)